#8468. Response to Tetangco and Hanauer

November 2026publication date
Proposal available till 30-05-2025
4 total number of authors per manuscript4500 $

The title of the journal is available only for the authors who have already paid for
Journal’s subject area:
Medicine (all);
Places in the authors’ list:
place 1place 2place 3place 4
FreeFreeFreeFree
1350 $1200 $1050 $900 $
Contract №8468.1 Contract №8468.2 Contract №8468.3 Contract №8468.4
1 place - free (for sale)
2 place - free (for sale)
3 place - free (for sale)
4 place - free (for sale)

Abstract:
We discuss the unnecessary use of, and rationale behind stopping, the 5-ASA therapy for ulcerative colitis. The study also suggests more effective alternatives to 5-ASAs.
Keywords:
ulcerative colitis; 5-ASA; cost-effective; safety; failure; clinical remission; discontinuation; high-quality care

Contacts :
0